The number of people getting treatment for pre-exposure prophylaxis (PrEP) against the human immunodeficiency virus (HIV) in France has been rising over the years. Among those who used such a treatment with Truvada or a generic equivalent between January 2016 and June 2021, **** percent were younger than ** and * percent were older than 65 years. During this period, most PrEP users in France were aged 26 to 35.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
ANSM. (November 30, 2021). Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by age group [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 24, 2026, from /statistics/1116573/hiv-aids-prep-users-france-age/
ANSM. "Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by age group." Chart. November 30, 2021. ÌÇÐÄÆƽâ°æ. Accessed July 24, 2026. /statistics/1116573/hiv-aids-prep-users-france-age/
ANSM. (2021). Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by age group. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 24, 2026. /statistics/1116573/hiv-aids-prep-users-france-age/
ANSM. "Distribution of People Treated with Truvada® or Generic for Pre-exposure Prophilaxis (Prep) between January 2016 and June 2021, by Age Group." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 30 Nov 2021, /statistics/1116573/hiv-aids-prep-users-france-age/
ANSM, Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by age group ÌÇÐÄÆƽâ°æ, /statistics/1116573/hiv-aids-prep-users-france-age/ (last visited July 24, 2026)
Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by age group [Graph], ANSM, November 30, 2021. [Online]. Available: /statistics/1116573/hiv-aids-prep-users-france-age/
